CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,532,810 | -25.0% | 1,188,225 | 0.0% | 0.01% | -18.2% |
| Q2 2023 | $2,043,747 | +13.9% | 1,188,225 | 0.0% | 0.01% | -8.3% |
| Q1 2023 | $1,794,220 | -11.8% | 1,188,225 | -6.5% | 0.01% | +20.0% |
| Q4 2022 | $2,033,440 | +10.3% | 1,270,900 | 0.0% | 0.01% | -9.1% |
| Q3 2022 | $1,843,000 | -20.8% | 1,270,900 | 0.0% | 0.01% | -69.4% |
| Q2 2022 | $2,326,000 | – | 1,270,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
| Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
| Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
| RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
| Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
| Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
| WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |